For the Inventor, By the Inventor

Enter assignee name

King of Prussia, PA, United States of America

Cytokine Pharmasciences, Inc.

USPTO Granted Patents = 16

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 44

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Richard J Bucala (5 out of 57 patents)

Thais Motria Sielecki-Dzurdz (4 out of 9 patents)

Yousef Al-Abed (3 out of 37 patents)

4. Anthony Cerami (3 out of 167 patents)

5. Michael I Bukrinsky (3 out of 21 patents)

6. Kevin J Tracey (2 out of 89 patents)

7. Pamela Cohen (2 out of 7 patents)

8. Helena Schmidtmayerova (2 out of 3 patents)

9. Robert A Mitchell (2 out of 9 patents)

10. Jurgen Bernhagen (2 out of 5 patents)

11. Thierry F Calandra (2 out of 5 patents)

12. Peter Gregersen (1 out of 9 patents)

13. Lin Leng (1 out of 5 patents)

14. Christine N Metz (1 out of 7 patents)

15. John A Baugh (1 out of 2 patents)

16 patents: Sort by Forward Citations

1. 8034840 - Guanylhydrazone salts, compositions, processes of making, and methods of using (2011-10-11),

2. 7928130 - Isoxazoline compounds having MIF antagonist activity (2011-04-19),

3. 7863334 - Guanylhydrazone compounds, compositions, methods of making and using (2011-01-04),

4. 7795314 - Protective role of semapimod in necrotizing enterocolitis (2010-09-14),

5. 7741372 - Guanylhydrazones useful for treating diseases associated with T cell activation (2010-06-22),

6. 7741057 - Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor (2010-06-22),

7. 7662843 - Isoxazoline compounds having MIF antagonist activity (2010-02-16),

8. 7517523 - Anti-MIF antibodies (2009-04-14),

9. 7491740 - Isoxazoline compounds having MIF antagonist activity (2009-02-17),

10. 7291647 - Guanylhydrazone compounds, compositions, methods of making and using (2007-11-06),

11. 7244765 - Guanylhydrazone salts, compositions, processes of making and methods of using (2007-07-17),

12. 7205107 - Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease (2007-04-17),

13. 6998238 - Method for determining MIF content (2006-02-14),

14. 6906076 - Compounds and methods of use to treat infectious diseases (2005-06-14),

15. 6774227 - Therapeutic uses of factors which inhibit or neutralize MIF activity (2004-08-10),

Cytokine PharmaSciences, Inc. is a leading pharmaceutical company specializing in the research, development, and commercialization of novel cytokine-based therapies. Our innovative products aim to revolutionize the treatment of various inflammatory and autoimmune diseases. With a dedicated team of scientists and experts, we are committed to advancing medical science and improving patient outcomes. Learn more about our groundbreaking solutions on our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#9 in King of Prussia, PA

#712 in Pennsylvania

#19,310 in US

#36,676 in the World

King of Prussia, PA, United States of America

Cytokine Pharmasciences, Inc.

Forward Citations = 44

25 inventors:

Richard J Bucala (5 out of 57 patents)

Thais Motria Sielecki-Dzurdz (4 out of 9 patents)

Yousef Al-Abed (3 out of 37 patents)

4. Anthony Cerami (3 out of 167 patents)

5. Michael I Bukrinsky (3 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…